|
|
|
Insider
Information: |
Westphal Christoph H |
Relationship: |
10% Owner |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
6,222,903 |
|
Indirect Shares
|
9,212,891 |
|
|
Direct
Value |
$5,876,236 |
|
|
Indirect Value
|
$370,354,860 |
|
|
Total
Shares |
15,435,794 |
|
|
Total
Value |
$376,231,096 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Momenta Pharmaceuticals Inc |
MNTA |
Director |
2004-06-25 |
0 |
2004-06-25 |
76,648 |
Premium* |
|
Alnylam Pharmaceuticals Inc |
ALNY |
Director, 10% Owner |
2004-05-27 |
0 |
2004-06-03 |
2,409,970 |
Premium* |
|
Verastem, Inc. |
VSTM |
Executive Chairman, Di... |
2015-06-30 |
665,224 |
2015-06-30 |
1,500,063 |
Premium* |
|
Tempest Therapeutics, Inc |
TPST |
Director, 10% Owner |
2014-03-07 |
701,927 |
2014-03-07 |
3,825,421 |
Premium* |
|
Salarius Pharmaceuticals, Inc |
SLRX |
10% Owner |
2018-10-16 |
3,941,118 |
2018-10-16 |
0 |
Premium* |
|
Tscan Therapeutics, Inc. |
TCRX |
10% Owner |
2021-07-20 |
914,634 |
2021-07-20 |
1,400,789 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
137 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VSTM |
Verastem, Inc. |
President and C.E.O. |
|
2012-12-21 |
4 |
A |
$8.72 |
$8,854 |
D/D |
1,000 |
710,469 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Executive Chairman |
|
2014-12-31 |
4 |
D |
$8.86 |
$24,542 |
D/D |
(2,770) |
677,789 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Chief Executive Officer |
|
2013-04-09 |
4 |
A |
$8.98 |
$9,068 |
D/D |
1,000 |
701,289 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Chief Executive Officer |
|
2013-03-21 |
4 |
AB |
$9.04 |
$7,232 |
D/D |
800 |
705,331 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Chief Executive Officer |
|
2013-06-07 |
4 |
AB |
$9.06 |
$9,056 |
D/D |
1,000 |
707,089 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Executive Chairman |
|
2015-01-08 |
4 |
D |
$9.19 |
$53,394 |
D/D |
(5,810) |
683,601 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Chief Executive Officer |
|
2013-05-21 |
4 |
AB |
$9.24 |
$7,393 |
D/D |
800 |
705,289 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Chief Executive Officer |
|
2013-03-13 |
4 |
A |
$9.32 |
$7,467 |
D/D |
800 |
704,531 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Chief Executive Officer |
|
2013-03-12 |
4 |
D |
$9.37 |
$345,416 |
D/D |
(36,864) |
703,731 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Chief Executive Officer |
|
2013-05-30 |
4 |
A |
$9.40 |
$7,525 |
D/D |
800 |
706,089 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Chief Executive Officer |
|
2013-04-02 |
4 |
D |
$9.44 |
$55,148 |
D/D |
(5,842) |
700,289 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Chief Executive Officer |
|
2013-03-05 |
4 |
AB |
$9.47 |
$7,576 |
D/D |
800 |
740,595 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Executive Chairman |
|
2014-06-30 |
4 |
D |
$9.52 |
$52,646 |
D/D |
(5,530) |
694,734 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Chief Executive Officer |
|
2013-04-17 |
4 |
AB |
$9.53 |
$7,624 |
D/D |
800 |
702,089 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Chief Executive Officer |
|
2013-04-01 |
4 |
A |
$9.55 |
$7,685 |
D/D |
800 |
706,131 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Director |
|
2013-11-18 |
4 |
AB |
$9.60 |
$9,602 |
D/D |
1,000 |
696,872 |
0 |
- |
|
SLRX |
Salarius Pharmaceuticals,... |
President and CEO |
|
2016-03-15 |
4 |
B |
$9.62 |
$185,060 |
I/I |
19,237 |
2,806,181 |
2.64 |
- |
|
VSTM |
Verastem, Inc. |
Chief Executive Officer |
|
2013-02-06 |
4 |
A |
$9.65 |
$7,919 |
D/D |
800 |
738,995 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Chief Executive Officer |
|
2013-05-13 |
4 |
A |
$9.70 |
$7,828 |
D/D |
800 |
704,489 |
0 |
- |
|
VSTM |
Verastem, Inc. |
President and C.E.O. |
|
2013-01-02 |
4 |
AB |
$9.73 |
$7,784 |
D/D |
800 |
711,269 |
0 |
- |
|
SLRX |
Salarius Pharmaceuticals,... |
President and CEO |
|
2016-05-09 |
4 |
B |
$9.80 |
$171,814 |
I/I |
17,532 |
2,978,050 |
2.64 |
- |
|
VSTM |
Verastem, Inc. |
Chief Executive Officer |
|
2013-05-03 |
4 |
AB |
$9.83 |
$7,862 |
D/D |
800 |
703,689 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Chief Executive Officer |
|
2013-04-25 |
4 |
A |
$9.89 |
$7,917 |
D/D |
800 |
702,889 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Chief Executive Officer |
|
2013-02-25 |
4 |
A |
$9.93 |
$7,972 |
D/D |
800 |
739,795 |
0 |
- |
|
SLRX |
Salarius Pharmaceuticals,... |
President and CEO |
|
2016-05-12 |
4 |
B |
$9.94 |
$160,004 |
I/I |
16,097 |
3,020,844 |
2.64 |
- |
|
137 Records found
|
|
Page 2 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|